panax ginseng liposomal
Selected indexed studies
- Pharmacological mechanisms and drug delivery systems of ginsenoside Rg3: A comprehensive review. (Pharmacol Res, 2025) [PMID:40414584]
- Ocotillol-Type Pseudoginsenoside-F11 Alleviates Lipopolysaccharide-Induced Acute Kidney Injury through Regulation of Macrophage Function by Suppressing the NF-κB/NLRP3/IL-1β Signaling Pathway. (J Agric Food Chem, 2024) [PMID:39239930]
- Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer's Disease. (Biomolecules, 2025) [PMID:41594549]
_Worker-drafted node — pending editorial review._
Connections
panax ginseng liposomal helps
panax ginseng liposomal protects against
Sources
- Pharmacological mechanisms and drug delivery systems of ginsenoside Rg3: A comprehensive review. (2025) pubmed
- Ocotillol-Type Pseudoginsenoside-F11 Alleviates Lipopolysaccharide-Induced Acute Kidney Injury through Regulation of Macrophage Function by Suppressing the NF-κB/NLRP3/IL-1β Signaling Pathway. (2024) pubmed
- Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer's Disease. (2025) pubmed
- Recent advances in nano and micro formulations of Ginsenoside to enhance their therapeutic efficacy. (2024) pubmed
- Novel Nanoformulations to Overcome Obstacles in Herbal Drug Delivery for Alzheimer's Disease. (2025) pubmed
- Plant-derived secondary metabolites and nanotechnology: innovative strategies and emerging challenges in myocardial ischemia-reperfusion injury therapy. (2025) pubmed
- Recent advances in delivery systems of ginsenosides for oral diseases. (2025) pubmed
- Natural Medicine and 3D Printing for Tissue Repair, Drug Delivery, and Wound Healing: Integrating Traditional Chinese Medicine Bio-Actives with Advanced Biomaterials. (2025) pubmed
- Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats. (2012) pubmed
- Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. (2021) pubmed